ONCOLYTICS BIOTECH INC/ CA6823108759 /
| 5/29/2024 9:59:59 PM | Chg. 0.00 | Volume | Bid10:00:08 AM | Ask10:00:08 AM | High | Low |
|---|---|---|---|---|---|---|
| 1.49CAD | 0.00% | 69,915 Turnover: 106,414 |
1.46Bid Size: 2,000 | 1.55Ask Size: 100 | 1.57 | 1.48 |
GlobeNewswire
5/24
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7...
Newsfile Corp
3/6
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
GlobeNewswire
3/5
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Trea...
Newsfile Corp
2/15
Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
GlobeNewswire
2/14
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focu...
GlobeNewswire
1/9
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
12/12/2018
Oncolytics Biotech® Announces First Patient Treated in Study Combining Pelareorep, Carfilzomib and t...
GlobeNewswire
12/3/2018
Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasom...
GlobeNewswire
11/29/2018
Oncolytics Biotech® Announces Appointment of Rita Laeufle, M.D., as Chief Medical Officer
GlobeNewswire
11/26/2018
Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytru...
GlobeNewswire
11/12/2018
Oncolytics Biotech® Reports 2018 Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire
11/9/2018
Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Me...
GlobeNewswire
11/5/2018
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Corporat...
GlobeNewswire
11/1/2018
Oncolytics Biotech® Announces Abstract for ASH Annual Meeting & Exposition Demonstrating Pelareorep ...
GlobeNewswire
10/22/2018
Oncolytics Biotech® Announces Positive Clinical Trial Results for Pelareorep in Patients with KRAS M...
GlobeNewswire
10/11/2018
Oncolytics Biotech® Announces Publication of Positive Clinical Results for Pelareorep in Abstract f...
GlobeNewswire
10/2/2018
Oncolytics Biotech® Announces a Publication Demonstrating That Intravenously Delivered Oncolytic Vir...
GlobeNewswire
9/28/2018
Oncolytics Biotech® Enters into Common Stock Purchase Agreement for up to US$26 Million with Lincoln...
GlobeNewswire
9/26/2018
Oncolytics Biotech® to Present at the Ladenburg Thalmann 2018 Healthcare Conference
GlobeNewswire
9/17/2018
Oncolytics Biotech® Announces Investigator Sponsored Multiple Myeloma Study Combining REOLYSIN® and ...
GlobeNewswire
9/10/2018
Oncolytics Biotech® Collaborates with SOLTI to Conduct a Window of Opportunity Study in Breast Cance...
